UTI - BSE Sensex Next 50 Exchange Traded Fund

UTI - BSE Sensex Next 50 Exchange Traded Fund sits in the middle of the pack for Other ETFs funds, currently carrying a 1-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 64/100.

Cost: At 0.2%, the expense ratio is meaningfully cheaper — about 43% below the Other ETFs category average of 0.35% (based on 279 comparable funds). Lower costs compound in your favour over long holding periods.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.03 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 16.41% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Other fund. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.